Infuence of HbA1c, serum lipids, blood pressure and BMI on Auditory Brainstem Response in diabetic patients
DOI:
https://doi.org/10.15584/ejcem.2017.3.1Keywords:
auditory brainstem response, diabetes mellitus, serum lipidsAbstract
Introduction. Impaired hearing organ function including abnormalities in auditory brainstem response (ABR) are more frequent in diabetic subjects compared to the general population.
Aim. The aim of our study was to assess the impact of selected modifiable factors on ABR latencies in diabetic subjects.
Material and methods. 58 patients with type 1 and type 2 diabetes, aged <45 years, with diabetes duration <10 years, and without clinically overt hearing impairment or diabetic neuropathy, were included. In all subjects vital signs and blood samples were obtained, and ABR audiometry was performed.
Results. Significantly delayed latencies in ABR were found in patients with total cholesterol 89 mg/dL, with presence of hypertension, and with systolic and diastolic blood pressure >135 and >78 mm Hg respectively. A linear correlation between triglycerides and wave I and III latencies, and between systolic blood pressure and wave III latency were revealed. A relationship between ABR latencies and HbA1c, LDL-cholesterol or BMI was not found.
Conclusions. Several modifiable factors affect functioning of the retrocochlear part of the auditory pathway. If these results were confirmed in further studies, a vast area of possible therapeutic interventions to preserve hearing function in diabetic patients would become available.
Downloads
References
Horikawa C, Kodama S, Tanaka S, et al. Diabetes and risk of hearing impairment in adults: a meta-analysis. J Clin Endocrinol Metab. 2013;98:51-58.
American Diabetes Association. Standards of Medical Care in Diabetes – 2017. Comprehensive Medical Evaluation and Assessment of Comorbidities. Diabetes Care. 2017;40(1):25–32.
Taylor IG, Irwin J. Some audiological aspects of diabetes mellitus. J Laryngol Otol. 1978;92:99-113.
Teng ZP, Tian R, Xing FL, et al. An association of type 1 diabetes mellitus with auditory dysfunction: A systematic review and meta-analysis. Laryngoscope. 2017;127(7):1689-1697.
Akinpelu OV, Mujica-Mota M, Daniel SJ. Is type 2 diabetes mellitus associated with alterations in hearing? A systematic review and meta-analysis. Laryngoscope. 2014;124:767-776.
Cheng YJ, Gregg EW, Saaddine JB, Imperatore G, Zhang X, Albright AL. Three decade change in the prevalence of hearing impairment and its association with diabetes in the United States. Prev Med. 2009;49:360-364.
Jewett DL, Romano MN, Williston JS. Human Auditory Evoked Potentials: Possible brain stem components detected on the scalp. Science. 1970;167:1517-1518.
Burkard R, McNerney. Introduction to auditory evoked potentials. In: Katz J. ed. Handbook of clinical audiology. Sixth Edition. Baltimore: Wolters Kluwer / Lippincot Williams & Wilkins;2009:222-241.
Mihanatzidou E, Kerlew R. The Link between Diabetes Mellitus and Sensorineural Hearing Loss: A Summary of the Evidence. Can Hear Rep. 2014;9:24–26.
Bainbridge KE, Cheng YJ, Cowie CC. Potential mediators of diabetes-related hearing impairment in the U.S. population: National Health and Nutrition Examination Survey 1999–2004. Diabetes Care. 2010;33:811-816.
Dąbrowski M, Mielnik-Niedzielska G, Nowakowski A. The impact of different modifiable factors on hearing function in type 1 and type 2 diabetic subjects. A preliminary study. Ann Agricult Environment Med. 2013;20:773-778.
Erdem T, Ozturan O, Cem Miman M, Ozturk C, Karatas E. Exploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissions. Eur Arch Otorhinolaryngol. 2003;260:62-66.
Duck SW, Prazma J, Bennett PS, Pillsbury HC. Interaction between hypertension and diabetes mellitus in the pathogenesis of sensorineural hearing loss. Laryngoscope. 1997;107:1596-1605.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
Polskie Towarzystwo Diabetologiczne (Polish Diabetes Association). Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2017 (Clinical practice recommendations on the management of patients with diabetes 2017). Clin Diabetol. 2017;6(A):9-11.
Virtaniemi J, Laakso M, Kärjä J, Nuutinen J, Karjalainen S. Auditory brainstem latencies in type 1 (insulin-dependent) diabetic patients. Am J Otolaryngol. 1993;14:413-418.
Konrad-Martin D, Austin DF, Griest S, McMillan GP, McDermott D, Fausti S. Diabetes-related changes in auditory brainstem responses. Laryngoscope. 2010;120:150-158.
Rance G, Chisari D, O’Hare F, et al. Auditory neuropathy in individuals with Type 1 diabetes. J Neurol. 2014;261:1531-1536.
Hou Y, Xiao X, Ren J, Wang Y, Zhao F. Auditory impairment in young type 1 diabetics. Arch Med Res. 2015;46:539-545.
Abo-Elfetoh NM, Mohamed ES, Tag LM, El-Baz MA, Ez Eldeen ME. Auditory dysfunction in patients with type 2 diabetes mellitus with poor versus good glycemic control. Egypt J Otolaryngol. 2015;31:162-169.
Sushil MI, Muneshwar JN, Afroz S. To study brain stem auditory evoked potential in patients with type 2 diabetes mellitus - A cross-sectional comparative study. J Clin Diagn Res. 2016;10:CC01-CC04.
Ben-David Y, Pratt H, Landman L, Fradis M, Podoshin L, Yeshurun D. A comparison of auditory brain stem evoked potentials in hyperlipidemics and normolopemic subjects. Laryngoscope. 1986;96:186-189.
Bhattacharjee S, Mondol M, Kashyap R. Effect of hypertension and hypercholesterolemia on auditory brainstem response in adults. Int J Med Health Sci. 2016;5:267-271.
Kassem HS, Azar ST, Zantout MS, Sawaya RA. Hypertriglyceridemia and peripheral neuropathy in neurologically asymptomatic patients. Neuroendocrinol Lett. 2005;26: 775-779.
Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 2009;58:1634-1640.
Kempler P, Tesfaye S, Chaturvedi N, et al. and EURODIAB IDDM Complications Study Group. Autonomic neuropathy is associated with increased cardiovascular risk factors: The EURODIAB IDDM Complications Study. Diabetic Med. 2002;19:900-909.
Voulgari C, Psallas M, Kokkinos A, Argiana V, Katsilambros N, Tentolouris N. The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes. J Diabetes Complications. 2011;25:159-167.
Tandon OP, Ram D, Awasthi R. Brainstem auditory evoked responses in primary hypertension. Indian J Med Res. 1996;104:311-315.
Khullar S, Gupta N, Babbar R. Auditory brainstem responses & nerve conduction velocity in essential hypertension. Vasc Dis Prev. 2009;6:51-55.
Goyal GL, Mittal A, Chaudhary C, Bachhel R, Grewal S, Rai M. The impact of severity of hypertension on auditory brainstem responses. Int J Med Publ Health. 2014;4:218-221.
Fransen E, Topsakal V, Hendrickx J-J, et al. Occupational noise, smoking, and a high body mass index are risk factors for age-related hearing impairment and moderate alcohol consumption is protective: A European population-based multicenter study. J Assoc Res Otolaryngol. 2008;9:264-276.
Wackym PA, Linthicum Jr FH. Diabetes mellitus and hearing loss: clinical and histopathological relationship. Am J Otol. 1986;7:176–182.
Fukushima H, Cureoglu S, Schachern PA, et al. Cochlear changes in patients with type 1 diabetes mellitus. Otolaryngol Head Neck Surg. 2004;133:100–106.
Kariya S, Cureoglu S, Fukushima H, et al. Comparing the cochlear spiral modiolar artery in type-1 and type-2 diabetes mellitus: A human temporal bone study. Acta Med Okayama. 2010;64:375-383.
Davis TM, Yeap BB, Davis WA, Bruce DG. Lipid lowering therapy and peripheral sensory neuropathy in type 2 diabetes: The Fremantle Diabetes Study. Diabetologia. 2008;51:562-566.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
